Variant report
Variant | esv3470670 |
---|---|
Chromosome Location | chr5:119038074-119041696 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs331902 | chr5:119041217-119041218 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs112484099 | chr5:119041240-119041241 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs371201357 | chr5:119041264-119041265 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs567264143 | chr5:119041269-119041270 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148326681 | chr5:119041314-119041315 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs181351221 | chr5:119041319-119041320 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs200456608 | chr5:119041348-119041349 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569796529 | chr5:119041398-119041399 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114239293 | chr5:119041445-119041446 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs558431227 | chr5:119041474-119041475 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185428654 | chr5:119041504-119041505 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191158322 | chr5:119041505-119041506 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs180775275 | chr5:119041514-119041515 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573991061 | chr5:119041521-119041522 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs187501432 | chr5:119041540-119041541 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs531724621 | chr5:119041542-119041543 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs367889544 | chr5:119041551-119041552 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538058726 | chr5:119041568-119041569 | Weak transcription Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs564784402 | chr5:119041603-119041604 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs527447198 | chr5:119041604-119041605 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs141238831 | chr5:119041605-119041606 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs4895202 | chr5:119041644-119041645 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs201451052 | chr5:119041691-119041692 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs113544368 | chr5:119041694-119041695 | ZNF genes & repeats Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:119041200-119041400 | Enhancers | Rectal Mucosa Donor 31 | rectum |
2 | chr5:119041200-119041600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr5:119041400-119041800 | Enhancers | Colonic Mucosa | Colon |
4 | chr5:119041400-119041800 | Flanking Active TSS | Rectal Mucosa Donor 31 | rectum |
5 | chr5:119041600-119042200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |